About Cryo-Cell
Cryo-Cell is a publicly listed company based in Oldsmar (United States) founded in 1989. Cord blood and tissue stem cells are stored for preservation. The company has 82 employees. Cryo-Cell has completed 1 acquisition, including CORD:USE Cord Blood. Its website cryo-cell.com draws about 40 thousand monthly visits. Its focus areas include Services for Healthcare Providers, Tissue and Organ Banks, Stem Cell Banks and Cord Blood. Its competitors include BioLife Plasma Services, FamilyCord and Mid-America Transplant.
Company details
Cryo-Cell is a cord blood bank to separate and store stem cells. The company services include umbilical cord blood, cord tissue, and menstrual stem cell banking. The premium service includes cryopreservation of cord tissue mesenchymal stem cells that can differentiate into bone, muscle, fat, and cartilage tissue.
- Annual Revenue$31.57 M (USD)-1.31as on Nov 30, 2025
- Net Profit-$2.43 M (USD)-704.18as on Nov 30, 2025
- EBITDA$1.85 M (USD)-61.55as on Nov 30, 2025
- Latest Funding Round$1.8M (USD), Post-IPO
Dec 1999
- Employee Count82
- Investments & Acquisitions
Apps and channels of Cryo-Cell
its YouTube channel Cryo-Cell International has 325 subscribers and 19 videos.
Videos from Cryo-Cell
The most watched videos on Cryo-Cell's YouTube channel, Cryo-Cell International (325 subscribers). Click a video to play it here.
More on Cryo-Cell International.
Funding Insights of Cryo-Cell
- Total Rounds 2
- Last Round Post-IPO — $1.8M
- First Round $1.1M
(Nov 1999)
All 2 funding rounds of Cryo-Cell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 1999 | $1.8M | Post-IPO | – | – | – |
| Nov 1999 | $1.1M | Post-IPO | – | – | – |
People of Cryo-Cell
5 people are tracked at Cryo-Cell (1 in leadership, 2 in board & advisors, 2 in team); the tracked headcount is 82.
| Name | Role | Group |
|---|---|---|
David I. Portnoy | Chairman of the Board and Co-Chief Executive Officer | Leadership |
Joanne Kurtzberg | Medical & Scientific Advisor | Board & advisors |
Jonathan H. Wheeler | Medical & Scientific Advisor | Board & advisors |
Jim Royster | Solutions Architect | Team |
Oleg Mikulinsky | CIO | Team |
Complete people profiles for Cryo-Cell
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Cryo-Cell
Cryo-Cell is a publicly listed company on the AMEX with ticker symbol CCEL in USA, operating in the Transportation sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date21 Jan 1997
- Listed onNYSEAMERICAN: CCEL
- Listed entityCryo-Cell International, Inc.
- Exchange sectorTransportation
- ISINUS2288951088
- Share price$4.30 (-4.44% on the day) · 2026-10-13
- Market capitalisation$34.7M
- EPS (diluted, trailing year)$-0.24
- Volume (last session)15,244
Financials of Cryo-Cell
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $31.6M | -$2.4M | $1.9M |
| 2024 | $32.0M | $402,100 | $4.8M |
| 2023 | $31.3M | -$9.5M | $1.5M |
| 2022 | $30.3M | $2.8M | $6.3M |
| 2021 | $28.9M | $2.1M | $4.5M |
Detailed financial statements for Cryo-Cell
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cryo-Cell
Cryo-Cell has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CORD:USE Cord Blood.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of umbilical cord blood stem cell storage services | corduse.com | Orlando, United States | 2004 | Jun 2018 | $14M |
Complete acquisition details for Cryo-Cell
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cryo-Cell
5 dated milestones of Cryo-Cell across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Cryo-Cell is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $1.1M.
- Funding Latest funding round, Post-IPO, of $1.8M.
- Acquisition Acquires CORD:USE Cord Blood.
Competitors of Cryo-Cell
Cryo-Cell has 3 listed competitors in our database. They include BioLife Plasma Services, FamilyCord and Mid-America Transplant.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifeplasma.com | 1994 | Bannockburn, United States | 5 | BioLife Plasma Services collects high-quality plasma and processes it into lifesaving therapies. | ||
| familycord.com | 2008 | Los Angeles, United States | Provides comprehensive stem cell storage services for individuals. | |||
| midamericatransplant.org | 2015 | St. Louis, United States | Facilitates organ donations, supports families, manages transplant services, and educates communities. |
Detailed competitors of Cryo-Cell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cryo-Cell
The website of Cryo-Cell (cryo-cell.com) receives about 39.9K visits a month.
- Monthly visits39.9K
▲ 8.5% vs previous month
Websites whose visitors overlap most with Cryo-Cell. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| stemcyte.com | 100% | 4.6K | #3,369,040 | View details | |
| cdc.gov | 96% | 16.4M | #4,309 | View details | |
| cookbiotech.com | 92% | View details | |||
cryoviva.in | cryoviva.in | 89% | #3,793,767 | – | |
| indianpediatrics.net | 82% | #495,267 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for Cryo-Cell
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Healthcare Provider Support Services
3 companies that operate in the same segment as Cryo-Cell (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of self funded health plan | 2017 | New York, New York, United States | USD 224 M | 212 | ||
Provider of AI solutions for clinical, operational, and business outcomes | 2005 | Princeton, New Jersey, United States | USD 1.13 B | USD 465.22 M | 5,442 | |
AMN Healthcare is recognized as a leading healthcare staffing provider. | 1985 | San Diego, California, United States | USD 2.73 B | 2,970 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cryo-Cell
Complete news archive for Cryo-Cell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cryo-Cell
Cryo-Cell was founded in 1989 and raised its 1st funding round 10 years after it was founded.
Cryo-Cell is headquartered in Oldsmar, United States. It is registered at Oldsmar, Florida, United States.
Cryo-Cell has 82 employees.
Annual revenue of Cryo-Cell is $31.57M as on Nov 30, 2025.
Cryo-Cell is a cord blood bank to separate and store stem cells. The company services include umbilical cord blood, cord tissue, and menstrual stem cell banking. The premium service includes cryopreservation of cord tissue mesenchymal stem cells that can differentiate into bone, muscle, fat, and cartilage tissue.
Cryo-Cell's top competitors include BioLife Plasma Services, FamilyCord and Mid-America Transplant.
Yes, Cryo-Cell is publicly traded on AMEX under the ticker symbol CCEL.
Cryo-Cell has made 1 acquisition, including CORD:USE Cord Blood.